Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific V β T cell families
ConclusionsThese data demonstrate that a transplantation protocol involving only selective tumor-reactive donor T cell families is an effective immunotherapy and results in long-term survival in a mouse model of human MM. The results highlight the need to develop similar ATCT strategies for MM patients that result in enhanced survival without symptoms of GvHD.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Bone Marrow Transplant | Cancer | Cancer & Oncology | Immunotherapy | Myeloma | Stem Cell Therapy | Stem Cells | Transplants